NASDAQ:TOI Oncology Institute (TOI) Stock Price, News & Analysis $3.40 -0.08 (-2.30%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$3.42 +0.02 (+0.74%) As of 08/29/2025 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Oncology Institute Stock (NASDAQ:TOI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Oncology Institute alerts:Sign Up Key Stats Today's Range$3.31▼$3.5250-Day Range$2.05▼$4.2852-Week Range$0.13▼$4.50Volume1.57 million shsAverage Volume1.85 million shsMarket Capitalization$317.90 millionP/E RatioN/ADividend YieldN/APrice Target$7.00Consensus RatingBuy Company Overview The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. Read More Oncology Institute Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreTOI MarketRank™: Oncology Institute scored higher than 48% of companies evaluated by MarketBeat, and ranked 592nd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingOncology Institute has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageOncology Institute has only been the subject of 2 research reports in the past 90 days.Read more about Oncology Institute's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Oncology Institute is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oncology Institute is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Oncology Institute's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted12.11% of the float of Oncology Institute has been sold short.Short Interest Ratio / Days to CoverOncology Institute has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Oncology Institute has recently decreased by 23.08%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOncology Institute does not currently pay a dividend.Dividend GrowthOncology Institute does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted12.11% of the float of Oncology Institute has been sold short.Short Interest Ratio / Days to CoverOncology Institute has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Oncology Institute has recently decreased by 23.08%, indicating that investor sentiment is improving significantly. News and Social Media2.2 / 5News Sentiment0.94 News SentimentOncology Institute has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.09 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Oncology Institute this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for TOI on MarketBeat in the last 30 days. This is a decrease of -81% compared to the previous 30 days.MarketBeat Follows14 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Oncology Institute insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,959,013.00 in company stock.Percentage Held by InsidersOnly 8.50% of the stock of Oncology Institute is held by insiders.Percentage Held by InstitutionsOnly 36.86% of the stock of Oncology Institute is held by institutions.Read more about Oncology Institute's insider trading history. Receive TOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TOI Stock News HeadlinesFinancial Analysis: Oncology Institute (NASDAQ:TOI) and InnovAge (NASDAQ:INNV)August 26, 2025 | americanbankingnews.comOncology Institute management to meet virtually with B. RileyAugust 20, 2025 | msn.comThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.August 31 at 2:00 AM | Paradigm Press (Ad)The Oncology Institute: A Promising Company In A Growing SectorAugust 19, 2025 | seekingalpha.comThe Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South FloridaAugust 18, 2025 | finance.yahoo.comOncology Institute Announces New Board ChairmanAugust 14, 2025 | msn.comOncology Institute Inc options imply 16.2% move in share price post-earningsAugust 14, 2025 | msn.comOncology Institute reports Q2 EPS (15c) vs. (17c) last yearAugust 14, 2025 | msn.comSee More Headlines TOI Stock Analysis - Frequently Asked Questions How have TOI shares performed this year? Oncology Institute's stock was trading at $0.3090 at the beginning of the year. Since then, TOI stock has increased by 1,000.3% and is now trading at $3.40. How were Oncology Institute's earnings last quarter? The Oncology Institute, Inc. (NASDAQ:TOI) released its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.18) earnings per share (EPS) for the quarter. The company had revenue of $104.41 million for the quarter. Oncology Institute had a negative trailing twelve-month return on equity of 1,527.21% and a negative net margin of 14.26%. Read the conference call transcript. Who are Oncology Institute's major shareholders? Oncology Institute's top institutional investors include Tiff Advisory Services LLC (4.07%), Balyasny Asset Management L.P. (2.82%), Marshall Wace LLP (1.66%) and Geode Capital Management LLC (1.43%). Insiders that own company stock include Growth I LP M33, Daniel Virnich, Brad Hively, Richard A Barasch, Mark L Pacala, Matthew P Miller, Yale Podnos, Mohit Kaushal and Havencrest Healthcare Partners. View institutional ownership trends. How do I buy shares of Oncology Institute? Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Oncology Institute own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oncology Institute investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Arista Networks (ANET), Adobe (ADBE), AppLovin (APP) and CrowdStrike (CRWD). Company Calendar Last Earnings5/14/2025Today8/31/2025Next Earnings (Estimated)11/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:TOI CIK1799191 Webtheoncologyinstitute.com Phone562-735-3226FaxN/AEmployees660Year FoundedN/APrice Target and Rating Average Price Target for Oncology Institute$7.00 High Price Target$8.00 Low Price Target$6.00 Potential Upside/Downside+105.9%Consensus RatingBuy Rating Score (0-4)3.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$64.66 million Net Margins-14.26% Pretax Margin-15.56% Return on Equity-1,527.21% Return on Assets-34.25% Debt Debt-to-Equity Ratio14.58 Current Ratio1.62 Quick Ratio1.37 Sales & Book Value Annual Sales$393.41 million Price / Sales0.81 Cash FlowN/A Price / Cash FlowN/A Book Value($0.10) per share Price / Book-34.00Miscellaneous Outstanding Shares93,500,000Free Float85,557,000Market Cap$317.90 million OptionableNot Optionable Beta0.08 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:TOI) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.